To include your compound in the COVID-19 Resource Center, submit it here.

Alexo reports preliminary Phase I data for ALX148 in solid tumors and lymphoma

In November, Alexo Therapeutics Ltd. (Dublin, Ireland) reported preliminary data from 17 patients with advanced solid tumors and lymphoma

Read the full 192 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE